Guidelines for the treatment of malaria
Malaria is an important cause of death and illness in children and adults in tropical countries. Mortality, currently estimated at over a million people per year, has risen in recent years, probably due to increasing resistance to antimalarial medicines. Malaria control requires an integrated approa...
Saved in:
| 企业作者: | |
|---|---|
| 格式: | 图书 |
| 出版: |
Geneva :
World Health Organization,
c2006.
|
| 主题: | |
| 在线阅读: | http://www.loc.gov/catdir/toc/fy0702/2006471482.html |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
MARC
| LEADER | 00000cam a22000007a 4500 | ||
|---|---|---|---|
| 020 | |a 9241546948 |c TZS 10,000/= | ||
| 020 | |a 9789241546942 |c TZS 10,000/= | ||
| 040 | |a MUL |c MUL |b eng |e AACR | ||
| 082 | 0 | 0 | |a 616.9362028 WHO |2 22 |b 1 |
| 110 | |a World Health Organization | ||
| 245 | 0 | 0 | |a Guidelines for the treatment of malaria |c / World Health Organization |
| 260 | |a Geneva : |b World Health Organization, |c c2006. | ||
| 300 | |a viii, 253 p. : |b ill. ; |c 24 cm. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | |a Preliminaries; Contents; 1 Introduction; 2 The clinical disease; 3 Treatment objectives; 4 Diagnosis of malaria; 5 Resistance to antimalarial medicines; 6 Antimalarial treatment policy; 7 Treatment of uncomplicated P falciparum malaria; 8 Treatment of severe falciparum malaria; 9 Treatment of malaria caused by P vivax P ovale or P malariae; 10 Mixed malaria infections; 11 Complex emergencies and epidemics; Annex 1. The guidelines development process; Annex 2. Adaptation of Who malaria treatment guidelines for use in countries; Annex 3. Pharmacology of antimalarial drugs. Annex 4. Antimalarials and malaria transmissionAnnex 5. Malaria diagnosis; Annex 6. Resistance to antimalarials; Annex 7. Uncomplicated P. falciparum malaria; Annex 8. Malaria treatment and Hiv/Aids; Annex 9. Treatment of severe P. falciparum malaria; Annex 10. Treatment of P. vivax, P. ovale and P. malariae infections; Index | ||
| 520 | |a Malaria is an important cause of death and illness in children and adults in tropical countries. Mortality, currently estimated at over a million people per year, has risen in recent years, probably due to increasing resistance to antimalarial medicines. Malaria control requires an integrated approach comprising prevention including vector control and treatment with effective antimalarials. The affordable and widely available antimalarial chloroquine which was in the past a mainstay of malaria control is now ineffective in most falciparum malaria endemic areas, and resistance to sulfadoxine-pyr | ||
| 546 | |a eng | ||
| 650 | 0 | |a Malaria | |
| 650 | 0 | |a Antimalarials. | |
| 650 | 0 | |a Malaria | |
| 650 | 2 | |a Malaria | |
| 650 | 2 | |a Antimalarials | |
| 650 | 2 | |a Malaria | |
| 650 | 1 | 7 | |a Malaria. |
| 650 | 7 | |a Malária (quimioterapia) | |
| 650 | 7 | |a Malária (diagnóstico) | |
| 650 | 7 | |a Antimaláricos (administração e dosagem) | |
| 710 | 2 | |a World Health Organization. | |
| 856 | 4 | 1 | |u http://www.loc.gov/catdir/toc/fy0702/2006471482.html |
| 942 | |c CC | ||
| 999 | |c 3612 |d 3612 | ||